Danish study links menopausal hormone therapy to risk of dementia, including Alzheimer’s


  • The association is greater when the prescription of the therapy is before the age of 55


  • Studies on this question have been inconclusive to date.


  • Some experts call for caution due to the similarity between some of the symptoms of menopause and the processes of cognitive deterioration

A study conducted using data from the Danish national health registry has associated menopausal hormone therapy with an increased risk of developing dementia, including Alzheimer’s. According to the research results, published in The BMJthis effect occurs especially when the prescription of the therapy was before the age of 55, a circumstance present in 80% of the cases.

Leave a Comment